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Circular RNAs (circRNAs), formed by non-sequential
back-splicing of pre-mRNA transcripts, are a wide-
spread form of non-coding RNA in animal cells. How-
ever, it is unclear whether the majority of circRNAs
represent splicing by-products without function or
are produced in a regulated manner to carry out
specific cellular functions. We show that hundreds
of circRNAs are regulated during human epithelial-
mesenchymal transition (EMT) and find that the pro-
duction of over one-third of abundant circRNAs is
dynamically regulated by the alternative splicing fac-
tor, Quaking (QKI), which itself is regulated during
EMT. Furthermore, by modulating QKI levels, we
show the effect on circRNA abundance is dependent
on intronic QKI binding motifs. Critically, the addition
of QKI motifs is sufficient to induce de novo circRNA
formation from transcripts that are normally linearly
spliced. These findings demonstrate circRNAs are
both purposefully synthesized and regulated by cell-
type specificmechanisms, suggesting they play spe-
cific biological roles in EMT.
INTRODUCTION
Circular RNAs (circRNAs) were identified in the early 1990s as
transcripts with scrambled exon order (Nigro et al., 1991) and
continued to be reported for a number of transcripts over the
following two decades (Capel et al., 1993; Cocquerelle et al.,
1993; Gualandi et al., 2003; Suzuki et al., 2006; Zaphiropoulos,
1997). However, the advent of next generation sequencing has
illuminated circRNAs as an entire class of abundant, non-coding
RNAs ubiquitous among eukaryotes (Guo et al., 2014; Jeck and
Sharpless, 2014; Jeck et al., 2013; Lasda and Parker, 2014;
Memczak et al., 2013; Salzman et al., 2012, 2013; Wang et al.,
2014a; Wilusz and Sharp, 2013; Zhang et al., 2014). circRNAs
result from a non-canonical form of alternative splicing, most
commonly where the splice donor site of one exon is ligated to
the splice acceptor site of an upstream exon (Figure 1). Lacking
30 termini, circRNAs are non-polyadenylated and resistant todigestion of the RNAwith RNase R, a highly processive 30 exonu-
clease that non-specifically degrades linear RNA, but not circR-
NAs, attributes which are exploited in their sequencing and iden-
tification (Jeck and Sharpless, 2014).
The finding that circRNAs are widespread in human and ani-
mal tissues raises two important questions: what controls their
formation, and what are their function(s) (if any)? Because only
two specific circRNAs, cIRS-7/CDR1as and Sry, have had any
function ascribed to date, both acting asmicro (mi)RNA sponges
(Hansen et al., 2013; Memczak et al., 2013), it remains possible
that the majority of circRNAs are accidental by-products of
mis-splicing. However, mining of ENCODE sequence data has
revealed that patterns of circRNA expression can be cell-type
specific, suggesting their formation may be regulated, which in
turn would indicate they have functions (Salzman et al., 2013).
Recent reports indicate circRNA formation can be aided by the
close proximity of circRNA splice sitesmediated by complemen-
tary base pairing of inverted repeats in the introns flanking the
circRNA-forming exons and that many circRNAs rely on this for
their biogenesis (Ashwal-Fluss et al., 2014; Liang and Wilusz,
2014; Zhang et al., 2014). However, this intron-pairing phenom-
enon alone cannot explain how a single abundant transcript
common to a multitude of cells can host cell-type specific circR-
NAs (Jeck and Sharpless, 2014; Salzman et al., 2013). On the
other hand, regulated alternative splicing plays amajor role in ex-
panding the transcriptome is critical in development and in phys-
iological responses (Kalsotra and Cooper, 2011), making it likely
that splicing factors may participate in regulating circRNA
biogenesis. Indeed, production of a single circRNA from the
pre-mRNA of theMuscleblind splicing factor was recently shown
to be regulated by Muscleblind itself (Ashwal-Fluss et al., 2014).
However, it is not known whether Muscleblind or other factors
can regulate circRNAs on a wider scale.
Quaking, which belongs to the STAR family of KH domain-
containing RNA binding proteins, has been found to affect pre-
mRNA splicing (Hall et al., 2013; Wu et al., 2002), mRNA turnover
(Larocque et al., 2005), and translation (Saccomanno et al., 1999)
and has been implicated in diseases including ataxia, schizo-
phrenia, and glioblastoma (Che´nard and Stephane, 2008). The
Quaking (QKI) gene is processed into three major isoforms of
5, 6, and 7 Kb, called QKI-5, QKI-6, and QKI-7, respectively,
that have substantially different 30UTRs, but differ by only about
30 amino acids in their C-termini and all of which retain the KHCell 160, 1125–1134, March 12, 2015 ª2015 Elsevier Inc. 1125
Figure 1. circRNAs Are Regulated in Human EMT
(A) Schematic depiction of alternative splicing isoforms generated from linear splicing (top) and back-splicing (bottom) of a four-exon transcript. The typical
locations of divergent primers used for quantitation of circRNAs by RT-PCR are shown as blue arrows.
(B) Phase contrast images of HMLE (epithelial) cells and mesHMLE (mesenchymal) cells resulting from TGF-b treatment for 21 days to induce EMT. Scale bar,
50 mm. Shown below is the relative abundance of prototypical EMT-regulated transcripts in HMLE andmesHMLE cells as determined by qRT-PCR normalized to
GAPDH. Values are mean ± SEM, n = 3.
(C) Distributions of total circRNAs (left) and circRNAs arising from abundant transcripts (FPKM >1.0) that were changed by <25% in EMT (right).
(D) Correlation of fold-change in abundance of each circRNA (y axis) and its cognate mRNA (x axis) following EMT. The individual distribution profiles of each are
shown above and to the right of the correlation plot.
(E) Relative abundance of circRNAs in HMLE and mesHMLE cells as determined by qRT-PCR normalized to GAPDH. Values are mean ± SEM, n = 3. See also
Figures S1 and S2; Tables S1 and S2.RNA binding domain. QKI 5, the most abundant isoform, is pre-
dominantly nuclear, while QKI-6 can be nuclear and cyto-
plasmic, and QKI-7 is predominantly cytoplasmic (Pilotte et al.,
2001). QKI dimerizes through its N-terminal Qua1 domain (Te-
plova et al., 2013) and binds bipartite sequence motifs (Galar-
neau and Richard, 2005) that can be on the same or separate
RNA molecules (Teplova et al., 2013). PAR-CLIP crosslinking
analysis in human embryonic kidney cells (HEK293T) indicates
the majority of QKI binding occurs within introns, consistent
with a role in splicing (Hafner et al., 2010).
Epithelial-mesenchymal transition (EMT) is a cellular differenti-
ation process important in embryo development, wound healing,
and in cancer metastasis (Nieto, 2013). The differentiation of an
epithelial cell into a mesenchymal cell involves drastic changes
in cell morphology, in gene expression patterns, and in arrange-1126 Cell 160, 1125–1134, March 12, 2015 ª2015 Elsevier Inc.ment and function of the actin cytoskeleton (Bracken et al.,
2014). EMT can be triggered by various ligand-receptor interac-
tions, including TGF-b, Wnt, and FGF, and involves extensive
regulatory networks that are controlled by transcription factors
and miRNAs (Lamouille et al., 2014). Because many cancers
arise from epithelial cells and need to undergo EMT to become
invasive and to metastasise, understanding the regulatory pro-
cesses involved in EMT may reveal new modalities for therapeu-
tic intervention in cancer progression.
We report here that the expression of hundreds of circRNAs is
regulated during EMT in response to TGF-b, with the majority of
regulated circRNAs increasing in abundance. To screen for RNA
binding proteins that regulate circRNA formation, we devised a
dual color reporter construct, called circScreen, allowing simul-
taneous quantification of linear and circRNA splicing. Using
circScreen, we identified the RNA binding protein Quaking (QKI)
as a major regulator of circRNA biogenesis in EMT. Furthermore,
we show that introduction of consensus binding sequences for
QKI into the flanking introns is sufficient to cause circRNAs to
be produced from exons that normally only undergo canonical
linear splicing. Because some of the most highly expressed
circRNAs are among those that are regulated in EMT, our find-
ings strongly suggest that certain circRNAs have EMT-related
functions and thus may affect mesenchymal cell properties
such as migration, invasion, and the propensity for cancers to
metastasise.
RESULTS
circRNA Formation in EMT
To assess whether circRNA production is regulated in EMT,
we harvested RNA from immortalized human mammary epithe-
lial (HMLE) cells before and after they had undergone EMT
in response to treatment with TGF-b. The TGF-b-treated cells
are stably mesenchymal with typical morphology and marker
expression and are referred to asmesHMLE cells (Figure 1B) (At-
tema et al., 2013; Mani et al., 2008). RNA from two biological rep-
licates of HMLE and mesHMLE cells was subjected to deep
sequencing, using library preparation procedures and bioinfor-
matics pipelines designed to detect circRNAs (refer to Experi-
mental Procedures). We detected 5,178 distinct circRNAs in
HMLE and 8,084 circRNAs in mesHMLE cells, of which 3,417
were common to both cell types (Figure 1C; Table S1). These
circRNAs are produced from 3,632 genes, meaning that circR-
NAs are not pervasive, rather being produced from approxi-
mately 22.5% of the transcriptome (16,138 genes with FPKM
>0.1) in these cells. To validate the circRNA analysis pipeline,
we selected a subset of circRNAs that vary in their abundance,
size, and genetic location and performed RT-PCR on RNase
R-treated RNA from HMLE and mesHMLE cells using circRNA-
specific divergent primers (Figure 1A). We successfully amplified
the expected product from 75/78 predicted circRNAs (Fig-
ure S1; Tables S1 and S2), authenticating our circRNA prediction
pipeline.
To check that the increase in circRNAs in mesHMLE cells was
a consequence of active regulation rather than a consequence of
increased transcription of the parent gene, we quantified circR-
NAs arising from abundant transcripts (FPKM >1.0) that were
largely unchanged (< 25% change) in EMT. The relative propor-
tions of these circRNAs in HMLE and mesHMLE cells were
similar to circRNAs derived from all transcripts (Figure 1C), indi-
cating that substantially more of these circRNAs were present in
mesenchymal cells than in epithelial cells. To assess whether
therewas a tendency for circRNAs that are present in HMLE cells
to increase in abundance following EMT, we analyzed all abun-
dant circRNAs common to HMLE and mesHMLE cells and
plotted the fold change in circRNA abundance against the
fold change in abundance of the cognate mRNA (Figure 1D).
While the mRNA fold changes exhibited a symmetrical, normal
distribution in response to TGF-b treatment, the circRNA profile
was positively shifted toward increased abundance (Figure 1D).
To verify this regulation, we performed quantitative (q)RT-PCR
using primers designed to measure several of the strongly regu-lated circRNAs, which confirmed that the circRNAs from POLE2,
OXNAD1, SHPRH, SMAD2, and ATXN2 were all increased over
40-fold by the TGF-b treatment, while circRNAs from DOCK1
and GNB1 were strongly decreased (Figure 1E).
To assess whether circRNA formation might be a mechanism
to encourage long range exon skipping in the parent transcript,
we analyzed the RNA sequencing data for evidence of mRNA
isoforms of SMARCA5, POLE2, SHPRH, SMAD2, and ATXN2
in which the circRNA-forming exons are skipped. We found in
most samples there were no reads corresponding to this form
of exon skipping. Where such exon skipping was detected,
it corresponded to <1% of the non-skipped mRNA isoform.
Thus, regulated circRNA formation does not appear to be a
mechanism for regulating exon skipping.
To check that the increases in circRNAs were not due to a
reduced cell proliferation rate following EMT, allowing more
accumulation of stable circRNAs, we measured the proliferation
rates of the HMLE and mesHMLE cells and found the prolifera-
tion rate of mesHMLE cells is actually higher than that of HMLE
cells (Figure S2). Thus, the increases in circRNA levels are
due to increased biogenesis. Furthermore, given that >62% of
circRNAs were cell-type-specific, being detected in only HMLE
or mesHMLE cells (Figure 1C), despite the similar abundance
of their cognate mRNA, this precludes complementary base-
pairing in introns alone as the mechanism of biogenesis for the
majority of circRNAs in these cells. Rather, these results suggest
substantial regulation of circRNA biogenesis, independent of
changes in abundance of the parental transcript during EMT.
A Focused Screen for Regulators of circRNA Formation
The regulation of circRNA formation during EMT suggests there
may be regulatory factors that participate in circRNA biogenesis.
We postulated that if a protein factor contributes to circRNA
biogenesis, it would also be regulated over the same time-
course. To provide a tool to screen for regulatory factors that
affect circRNA formation, we constructed a dual color fluores-
cent reporter, called circScreen, enabling simultaneous quantifi-
cation of both linear and circRNA splicing from a minigene
reporter construct (Figure 2A). The circScreen reporter construct
incorporates exons 14–17 of the SMARCA5 gene, a member
of the SWI/SNF family of chromatin remodelling proteins, which
are as frequently mutated in cancer as p53 (Wang et al., 2014b),
primarily chosen because (1) this region produces an abundant
circRNA comprised of exons 15 and 16, the abundance of
which was increased 8-fold following EMT (Figure 1E) with min-
imal change in the abundance of the linear mRNA transcript
(FPKMHMLE = 23.0, FPKMmesHMLE = 26.9), (2) it lacks comple-
mentary Alu elements, and (3) it is comprised of sufficiently small
exons and introns to permit a modest-sized reporter plasmid.
The reporter was constructed such that the normally untrans-
lated circRNA produced from the minigene undergoes IRES-
mediated translation of GFP, while the linear mRNA that is pro-
duced gives rise to red fluorescing mCherry (Figure 2A). Both
fluorescent proteins are tagged (GFP-FLAG, mCherry-HA) and
have nuclear localization signals inserted, confining them to
the nucleus to aid quantitation of cellular fluorescence (analysis
pipeline summarized in Figure S3). We verified that the reporter
was accurately spliced (Figure S4A) and gave rise to nuclearCell 160, 1125–1134, March 12, 2015 ª2015 Elsevier Inc. 1127
Figure 2. Identification of QKI as a circRNA
Biogenesis Factor Using the circScreen Re-
porter
(A) Schematic of the circScreen reporter construct
and fluorescence images of cells transfected with
circScreen. Nuclear green fluorescence is a mar-
ker of IRES-driven translation from circRNA; nu-
clear red fluorescence results from IRES-driven
translation from the linear mRNA.
(B) Effect of siRNA-mediated knockdown of EMT-
regulated RBPs on the ratio of circular to linear
RNAs produced from the circScreen reporter, as
measured by ratio of green to red corrected total
nuclear fluorescence (CTNF). There were two
different siRNAs that were used per target, shown
in white and black bars. Data were acquired from
measurements on 300 cells per experiment and
are presented as mean ± SEM, n = 3.
(C) Western blot of QKI, E-cadherin, and a-tubulin
(loading control) levels in HMLE and mesHMLE
cells. See also Figures S3 and S4.green fluorescence that could be almost eliminated by co-trans-
fection of either of two small interfering (si)RNAs targeting the
exon16/exon15 junction unique to the circRNA, without signifi-
cantly affecting mCherry levels (Figure 2B), as confirmed by
qPCR and western blot (Figure S4B).
To identify splicing-associated factors involved in circRNA
biogenesis, we first selected a candidate panel of nuclear RNA
binding proteins (RBPs) (based on Gene Ontology annotations)
that were expressed at appreciable levels (>0.1 FPKM in polyA+
RNA-sequencing from at least one sample) and were changed
in abundance by >2-fold, either up or down, following EMT
(Table 1). We also incorporated siRNAs that target the three
human homologs of Drosophila Muscleblind (MBNL1, MBNL2,
and MBNL3) implicated in circRNA biogenesis from its cognate
locus (Ashwal-Fluss et al., 2014). We examined the effect of
siRNA-mediated knockdown of each of these RBPs on circRNA
formation using the circScreen minigene reporter in the readily
transfectable HEK293T cell line, which has been shown to be
capable of circRNA formation from the SMARCA5 locus (Mem-
czak et al., 2013). The knockdown of most members of the
RBP panel, and all three MBNL homologs, had little effect on
the ratio of GFP:mCherry, but knockdown of QKI caused a sub-
stantial decrease in the ratio, indicating the QKI protein is
required for efficient formation of circRNA from this reporter (Fig-
ure 2B). The decrease in circRNA production on knockdown of
QKI was confirmed by western blotting and qRT-PCR, which
showed a reduction in tagged GFP reporter protein and in
circRNA, but not linear RNA from the transgenic and endoge-
nous genes (Figures S4C and S4D). Importantly, we confirmed
that QKI protein is increased in the cells that have undergone
EMT (Figure 2C) and is knocked down by >90% by siRNA-medi-
ated silencing (Figure S4E).1128 Cell 160, 1125–1134, March 12, 2015 ª2015 Elsevier Inc.QKI Regulates Formation of
circRNAs via Binding Sites in
Introns
The effect of QKI on circRNA formation
could conceivably be indirect, or couldbe through direct binding of QKI to the pre-mRNA. To assess
whether QKI binds the SMARCA5 pre-mRNA, we performed
RNA-immunoprecipitation (RIP) assays (Figure S5), using
qRT-PCR to quantify QKI occupancy within the introns adja-
cent to the circRNA-forming exons. We found that QKI binds
to the exon-adjacent sites at a level comparable to its binding
to a site in the previously validated QKI target, NUMB (Zong
et al., 2014), whereas binding to more remote regions else-
where in SMARCA5 and to the circRNA itself was negligible
(Figures 3A and 3B). To assess whether QKI binding sites in
the introns flanking the circRNA-forming exons of SMARCA5
are necessary for circRNA biogenesis, we searched for se-
quences that match potential QKI response elements in the
vicinity of the QKI RIP-enriched regions (Figures 3A and 3B)
and found four instances of a bipartite motif that contains
the sequence UAAY in conjunction with a relaxed version of
the canonical QKI hexamer previously determined by SELEX
(Galarneau and Richard, 2005). There are two of the putative
elements that are located upstream and two are located
downstream of the circRNA-forming splice sites, as shown in
Figure 3C. Mutation of any of the putative binding sites individ-
ually had little effect on circRNA formation, but mutation of both
members of either the upstream pair or the downstream pair
substantially reduced circRNA formation, while mutation of all
four sites was even more effective (Figure 3D). Knockdown of
QKI strongly reduced circRNA formation from the intact or
singly mutated reporter, but not from the reporter with both
members of the pair mutated, confirming the absence of off-
target effects on the reporter (Figure S4E). Together, these
data indicate that QKI binds upstream and downstream of
the circRNA-forming exons in SMARCA5 to promote circRNA
formation.
Table 1. EMT-Regulated Nuclear RBPs
RBP Gene Name Fold-Change (Log2)
ESRP1 9.4
ESRP2 2.3
ATXN1 1.1
QKI 1.1
WT1 2.1
BICC1 2.1
APOBEC3B 2.1
IFIT1 2.3
NANOS3 2.6
IGF2BP1 2.8
NOVA1 3.4
MSI1 3.5
MEX3B 3.7
NOVA2 7.1To more broadly assess the role of QKI in circRNA pro-
duction, we examined the effect of QKI knockdown on the
abundance of 13 circRNAs that were previously identified in
HEK293T cells (Memczak et al., 2013) and compared this
with the presence or absence of known QKI PAR-CLIP sites
(Hafner et al., 2010) in the introns flanking the circRNA-forming
exons. The abundance of all nine circRNAs with adjacent
QKI PAR-CLIP sites was reduced following QKI knockdown,
whereas the four that are devoid of adjacent sites were largely
unaffected (Figure 3E). To extend the identification of QKI-
dependent circRNAs in the EMT context, we performed RNA
sequencing on RNA from two biological replicates of mesHMLE
cells in which QKI was knocked down by siRNA treatment
and the abundances of the circRNAs were compared with
those in control mesHMLE cells. We found that there was a
strong bias toward decrease in circRNA abundance (Figure 3F).
Of the 300 most abundant circRNAs in mesHMLE cells, 105
were decreased more than 2-fold by QKI knockdown, whereas
only seven were increased by more than 2-fold (Figure 3F). We
also confirmed by qRT-PCR that the increase in circRNAs from
SMARCA5, POLE2, OXNAD1, SHPRH, SMAD2, and ATXN2
that occurred in EMT (Figure 1E) was abrogated by QKI knock-
down, while DOCK1 and GNB1, which lack QKI response
elements (QREs) in the adjacent introns, were unaffected by
QKI knockdown (Figure S4I). To investigate which of the
three isoforms of QKI is responsible for circRNA formation,
we knocked down each isoform individually in mesHMLE cells
and measured the levels of the QKI-dependent SMARCA5,
POLE2, SHPRH, SMAD2, and ATXN2 circRNAs by qRT-PCR.
The isoform-specific siRNAs that target QKI-6 and QKI-7 had
little effect on these circRNA levels, whereas the QKI-5-specific
siRNA reduced the level of all five circRNAs (Figures S4F and
S4G), indicating it is QKI-5 that is responsible for the circRNA
formation, consistent with this nuclear isoform acting on
circRNA formation during splicing. Consistent with a role for
QKI binding in regulating circRNA production in EMT, we found,
using the PAR-CLIP data of Hafner et al. (2010) to indicate po-
tential QKI binding sites, that the EMT-regulated circRNAs were1.3-fold more likely than unregulated circRNAs to have a QKI
site in a flanking intron and 2.1 times more likely to have QKI
sites in both flanking introns. Together, these data demonstrate
that QKI plays a major role in regulating circRNA production
during EMT.
To establish that circRNA regulation by QKI is sustained for
longer periods, QKI was stably knocked down by two different
QKI-specific small hairpin (sh)RNAs in mesHMLE cells, reducing
QKI protein by >85% (Figure 4A). Compared to a scrambled uni-
versal shRNA, the change in abundance of circRNAs measured
by qRT-PCR mimicked that for the siRNA (Figure 4B). Interest-
ingly, overexpression of QKI in mesHMLE cells (Figure 4C) in-
creased the circRNA abundance in two independent clones
(Figure 4D), revealing a quantitative positive correlation between
QKI abundance and circRNA biogenesis. This was confirmed
beyond the HMLE EMT model by performing qRT-PCR on
four circRNAs (SMARCA5, POLE2, SHPRH, and DOCK1) in the
prototypical epithelial (MCF7) and mesenchymal (MDA-MB-
231) breast cancer cell lines. The circRNAs from SMARCA5,
POLE2, and SHPRH, which are flanked by QKI PAR-CLIPmotifs,
weremore abundant in themesenchymal cell line, which express
over 2.5-fold more QKI transcript than MCF7 cells, while DOCK1
wasmore abundant in the epithelial cell line (Figure S6A). This in-
dicates that the relationship between QKI and circRNA produc-
tion is maintained in breast cancer cells.
Insertion of Synthetic QKI Binding Sites into Introns Is
Sufficient to Generate circRNA Formation
As a conclusive test of QKI-directed circRNA biogenesis, we
investigated whether exons that do not normally produce circles
could be made competent to produce circRNA by insertion of
QKI binding motifs into the adjacent introns. We selected four
genes, SYT8, ADD3, TIMP1, and NACAD, that are expressed,
but do not give rise to circRNAs in HMLE, mesHMLE, MDA-
MB-231, or HEK293T cells. Minigene expression vectors were
constructed to express a region encompassing three exons
from each of these genes, with and without canonical QKI bind-
ingmotifs (ACUAACN1–20UAACmotif determined by SELEX, see
Galarneau and Richard, 2005) inserted in both introns flanking
the central exon (Figure 5A). The minigenes were expressed in
HEK293T cells (Figure 5) and MDA-MB-231 cells (Figures S6B
and S6C) and assayed for circRNA formation by RT-PCR using
divergent primers that can only give a product from circularized
RNA (Figure 5B). None of the unmodifiedminigenes was capable
of producing a circRNA, including ADD3, which contains twoQKI
PAR-CLIP sites 50 to the central exon (Hafner et al., 2010). How-
ever, insertion of another intronic QRE downstream of the central
exon in ADD3, and insertion of QREs into both flanking introns for
the other three reporters resulted in production of circRNA from
eachminigene (Figure 5B), verified by sequencing of the RT-PCR
products and by their resistance to treatment with RNase R, an
exonuclease that degrades linear, but not circular, RNA (Fig-
ure 5B). To verify that the circRNA production was dependent
on QKI, the effect of siRNA-mediated QKI knockdown was
tested, and it was found that this largely abrogated circular,
but not linear product formation in the RT-PCR (Figure 5B),
consistent with circRNA production being dependent on QKI.
Together, our data show that QKI promotes circRNA productionCell 160, 1125–1134, March 12, 2015 ª2015 Elsevier Inc. 1129
Figure 3. QKI Binds to Pre-mRNA to Stimulate circRNA Biogenesis
(A) Schematic of SMARCA5 pre-mRNA showing the locations of four putative QREs (inverted blue triangles) and amplicons (A–F) used for RIP assay.
(B) RIP assay using the PCR primers indicated in (A). The validated QKI binding site in NUMB was used as a positive control.
(C) Schematic diagram showing locations and sequence of predicted QREs in the circScreen reporter gene. Numbers in brackets refer to the distance from the
circRNA forming splice site.
(D) Effect of mutations to the QREs on the ratio of circRNA to linear mRNA, as determined by ratios of CTNFGFP:mCherry. ***p < 0.001. Data were acquired from
measurements on 300 cells per experiment and are presented as mean ± SEM, n = 3.
(E) Effect of QKI knockdown on abundance of various circRNAs in HEK293T cells. The presence or absence of QKI binding sites in these genes, as determined by
PAR-CLIP assay by Hafner et al. (2010) is indicated. circRNAsweremeasured by qRT-PCRwith data presented as circRNA abundance relative to negative siRNA
control cells, mean ± SEM, n = 3.
(F) Ranked fold changes in circRNA abundance for the 300 most highly expressed circRNAs in mesHMLE cells following siRNA-mediated knockdown of QKI.
Data are means from two replicate experiments. See also Figures S4 and S5.from genes that have QKI binding sites appropriately located
within the introns.
DISCUSSION
From deep sequencing of RNA, we have detected thousands of
circRNAs present in HMLE epithelial cells and in their mesen-
chymal counterparts that are formed in response to prolonged
exposure to TGF-b. We verified that the sequence analysis pipe-
line appropriately identifies circRNAs by performing RT-PCR on
RNase R-treated RNA, using divergent primers that amplify
across the splice junction unique to the circular form of the
RNA. Consistent with previous studies on different cell types
(Guo et al., 2014; Jeck et al., 2013; Salzman et al., 2013), we
found that the majority of circRNAs in epithelial cells, and in their
mesenchymal derivatives, are of low abundance and conse-
quently could conceivably be the result of errors in pre-mRNA1130 Cell 160, 1125–1134, March 12, 2015 ª2015 Elsevier Inc.splicing, but certain circRNAs were present at substantial levels
that suggest they are purposefully produced. Furthermore, the
production of numerous abundant circRNAs was regulated in
response to TGF-b, independent of changes in their cognate
mRNA transcript, which strongly suggests they are produced
to carry out some function in these cells. Most of the circRNAs
whose level changed substantially in EMT were upregulated,
suggesting they carry out functions related to the mesenchymal
phenotype. A smaller number were also strongly changed in the
opposite direction, consistent with these circRNAs having
epithelial-specific functions. For example, the DOCK1 circRNA
is one of the most abundant circRNAs in the epithelial cells,
but was downregulated 30-fold in response to TGF-b. In light
of the observation that circRNA production competes with linear
splicing of pre-mRNA (Ashwal-Fluss et al., 2014), it is interesting
to note that the level of DOCK1 mRNA was increased (by about
2-fold) in response to TGF-b, raising the possibility that one
Figure 4. QKI Perturbs Numerous circRNAs
in mesHMLE
(A) Western blot of QKI and a-tubulin (loading
control) levels in mesHMLE cells stably transduced
with pLKO::scrambled shRNA (shScr), pLKO::QKI
shRNA 1 (shQKI1), and pLKO::QKI shRNA 2
(shQKI2).
(B) qRT-PCR of circRNAs frommesHMLE cells with
shRNA constructs. Data presented as circRNA
abundance relative to scrambled shRNA control
cells, mean ± SEM, n = 3.
(C) Western blot of QKI and a-tubulin (loading
control) levels in mesHMLE cells stably transduced
with pLX301::mCherry, pLX301::QKI clone #2, and
pLX301::QKI clone #4.
(D) qRT-PCR of circRNAs frommesHMLE cells with
QKI overexpression. Data presented as circRNA
abundance relative to pLX301::mCherry control
cells, mean ± SEM, n = 3.function of excision of the DOCK1 circRNA could be to con-
tribute to downregulation of DOCK1 mRNA in epithelial cells.
DOCK1 is a guanine nucleotide exchange factor (GEF) that acti-
vates Rac to enhance cell motility (Gadea and Blangy, 2014),
consistent with its upregulation in EMT. Nevertheless, because
the DOCK1 circRNA is so abundant in epithelial cells, it is
tempting to speculate that it has a function in these cells apart
from a role in reducing expression of the DOCK1 mRNA.
Our finding of frequent regulation of circRNA abundance in
EMT is a strong argument in favor of these circRNAs having func-
tions in the cell, although these functions remain largely un-
known. Just two circRNAs have had functions ascribed to
them to date: ciRS-7/CDR1as acts as a sponge for miR-7 in
mammalian cells, and a circRNA from the testes-specific Sry
gene acts as a sponge for miR-138 (Capel et al., 1993; Hansen
et al., 2013; Memczak et al., 2013). We searched for reiterated
miRNA binding sites in the circRNAs that are regulated by
TGF-b treatment of HMLE cells, but did not find any notable ex-
amples, suggesting they do not act as miR sponges. This obser-
vation is in agreement with the report of Guo et al. (2014) that the
majority of circRNAs appear to not function as miRNA sponges.
We observed that changes in circRNA levels were mostly in
the direction of increased abundance in the mesenchymal cells,
but at least for the more abundant circRNAs, their expression
was not exclusively mesenchymal. Several abundant circRNAs
were identified to change by 4–10-fold, while about 50 changed
by 2–4-fold, with many of these having substantial abundance in
the epithelial cells (Table S1). This contrasts with the almost
exclusively mesenchymal expression of key transcription factors
(such as ZEB1, Twist1, and Snail) that drive the mesenchymal
gene expression program and suggests that the functions of
the upregulated circRNAs are not likely to be exclusive to
mesenchymal cells. More relevant comparisons in this regard
may be to genes that are expressed in epithelial cells, but areCell 160, 1125–113increased in mesenchymal cells because
they participate in activities such as con-
trolling cell shape, ECM interactions, or
migration, which are more prominent inthemesenchymal phenotype. For example, some tubulin, cofilin,
and laminin transcripts have these features andweremoderately
increased in EMT.
Because circRNAs are likely to be quite stable, it is tempting to
speculate that the functions of some circRNAs may take advan-
tage of their long half-lives, allowing them to act as slow-re-
sponding regulators. A long half-life confers a slow approach
to steady-state level and a slow decline if their production
ceases. Furthermore, if the degradation rate is considerably
longer than the rate of cell division, the steady-state level
becomes sensitive to the cell division rate, which effectively
replaces degradation in determining the abundance of the
circRNA. EMT is a rather special type of induced cellular
response in that it causes a profound change in the differentia-
tion state of the cell, but at least in vitro, is readily reversible in
the initial days of induction, and then becomes more refractory
to reversion, but nevertheless remains reversible (Gregory
et al., 2011). This has parallels in vivo as exemplified by the rever-
sals of EMT that occur in some tissues during embryological
development, while reversible plasticity is thought to play an
important role in metastatic colonization (Brabletz, 2012; Nieto,
2013). Perhaps some circRNAs that are induced during EMT
could be involved in helping to determine the slow development,
or the duration, of a refractory mesenchymal state.
We have found that a substantial contribution to the regulation
of circRNA production in EMT comes from the regulation of
circularization by the mesenchymal splicing factor, QKI. QKI is
essential for enhanced production of many circRNAs and acts
by binding to recognition elements within introns, in the vicinity
of the circRNA-forming splice sites. Furthermore, insertion of
QKI motifs is sufficient to induce circRNA formation in contexts
where this is normally not observed. Secondary structure within
pre-mRNAs that brings circRNA-forming exons into close prox-
imity has been shown to enhance circRNA biogenesis (Liang and4, March 12, 2015 ª2015 Elsevier Inc. 1131
Figure 5. Introduction ofQKI-Binding Sites Promotes Novel circRNA
Formation
(A) Schematic showing sites of insertion of QREs and locations of PCR primers
used for segments of four genes (SYT8, ADD3, TIMP1, and NACAD) devoid of
circRNAs that were cloned into pcDNA3.1.
(B) Gel electrophoresis of RT-PCR products using circRNA-specific (upper
panels) andmRNA-specific primers (lower panels) on RNA fromHEK293T cells
transfected with the indicated minigenes, with siRNA-mediated silencing of
QKI or treatment with RNase R. See also Figure S6.Wilusz, 2014; Zhang et al., 2014). Since QKI is a dimer, capable
of binding two well separated regions of a single RNA molecule
(Teplova et al., 2013), it is an attractive possibility that QKI like-
wise promotes circRNA biogenesis by bringing the circle-form-
ing exons into close proximity.
Our observations that QKI levels are regulated in the EMT pro-
duced by TGF-b treatment of HMLE cells, and that QKI-regu-
lated circRNAs similarly change in abundance, suggest that
circRNAs could have important functions in EMT. Since EMT is
widely regarded to have an important role in the progression of
carcinomas to metastasis (Scheel and Weinberg, 2012; Tsai
and Yang, 2013) it will be interesting to examine the influence
of QKI-mediated circRNAs in cancers.
EXPERIMENTAL PROCEDURES
Cell Lines and Cell Culture
Human HMLE cell line cells were cultured and induced to undergo EMT as per
Mani et al. (2008) using 2 ng/ml1 TGF-b1 (Sigma-Aldrich). HEK293T, MCF-7,
and MDA-MB-231 immortalized breast cancer cells were maintained in Dul-
becco’s modified Eagle’s medium (DMEM) GlutaMax (Life Technologies)
with 10% (volume per volume) heat-inactivated fetal calf serum (Bovogen)
and 13 Penicillin-Streptomycin (Gibco) at 37C with 5% CO2.
qRT-PCR
Reverse transcription for mRNA and circRNAs were performed with Super-
Script III First-Strand Synthesis System (Life Technologies) and 50 ng random
hexamersor 2.5mMoligo (dT)20 aspermanufacturers instructions.miRNAqRT-
PCR was performed with TaqMan assay as per Gregory et al. (2008). RT-PCR
wassubsequently performed in triplicatewith a1:10dilutionof cDNAwith 13 iQ
SYBR Supermix (QIAGEN) on a Rotorgene 6000 series PCR machine (Corbett
Research). Analysis was performed as per Gregory et al. (2008).
Library Preparation
RNA was extracted from cells with TRIzol reagent (Life Technologies) and 4 mg
RNA was fractionated across three NEBNext Poly(A) mRNA Magnetic Isolation
Module columns. The supernatant was retained as the polyA-depleted fraction
(polyA) and the bead-bound (polyA+) fraction eluted from beads in elution
buffer/water according to manufacturer’s instructions. The polyA fraction
wassize-fractionatedandconcentratedusing3.53AMPureRNACleanXPsam-1132 Cell 160, 1125–1134, March 12, 2015 ª2015 Elsevier Inc.ple preparation (New England Biolabs) and eluted with water. Ribo-Zero Mag-
netic Gold Kit (Human/Mouse/Rat) (Epicenter) treatment was performed on
thepolyA fraction, purified, andsize-fractionatedwith1.73AMPureRNAClean
XP beads. Stranded RNA libraries were made using the NEBNext Ultra Direc-
tional RNA Library Prep Kit for Illumina (New England Biolabs) and multiplexed
between 2- and 4-index on HiSeq 2500, 100 base pairs (bp) paired-end reads.
Bioinformatics
Raw reads were adaptor trimmed and filtered for short sequences using cuta-
dapt v1.3 (Martin, 2011), using minimum-length 18, error-rate 0.2, overlap five,
paired-output options. The resulting FASTQ files were analyzed and quality
checked using the FastQC program (http://www.bioinformatics.babraham.
ac.uk/projects/fastqc). The remaining reads were mapped against the
GRChr37/hg19 human reference genome using the MapSplice spliced align-
ment algorithm (Wang et al., 2010) (version 2.1.8 beta, using parameters
–bam –fusion –fusion-non-canonical –filtering 1 –min_fusion_distance 200–
gene-gtf Ensembl). The number of reads supporting each circRNA junction
was obtained from the resulting splice junction files.
Normalization was performed using a set of 165 linear non-polyadenylated
‘‘housekeeping’’ transcripts judged to be ubiquitously and consistently
expressed across samples. This set included 39 small nucleolar RNA, 32
processed pseudogenes, 18 sense intronic elements, 18 snRNAs, eight large
intergenic non-coding RNAs, and six miRNAs. Specifically, after taking loga-
rithms, additive normalization factors were determined such that after normal-
ization the sample-averaged expression of the housekeeping RNAs was iden-
tical to the overall expression average. These sample-specific normalization
factors were then used to calculate appropriately normalized circRNA counts
for each sample. As a cross-check of the normalization procedure we used, for
a subset of the samples, a spike-in of a synthetic circRNA (refer to Extended
Experimental Procedures for in vitro transcription of circRNAs). We found
that, as expected, the normalization procedure tended to result in equilibrated
spike-in levels.
circScreen Reporter Construct
The genomic region of SMARCA5 was directionally cloned into pcDNA3.1
from HEK293T genomic DNA using primers SMARACA5_BamHI_F and
SMARACA5_NotI_R (all DNA oligonucleotides in Table S1) with Phusion Hot
Start Polymerase (Thermo Fisher Scientific) according to manufacturer’s in-
structions. Cytomegalovirus internal ribosomal entry site (CMV-IRES) was
amplified from pLMP-Cherry and cloned into the BstBI site of SMARCA5
Exon 16. GFPwas amplified from pDendra2 vector (Clontech) to include N-ter-
minal nuclear localization signal (NLS and KKKRKV) and C-terminal FLAG tag
(DYKDDDK) and cloned into the BsaBI site of SMARCA5 Exon 15. NLS-
mCherry-HA was generated from two overlapping gBlocks gene fragments
(Integrated DNA Technologies) into PflFI sites, inserting mCherry into Exon
17 to complete the circScreen reporter. Mutation of QREs and deletion of in-
verted repeats from the circScreen reporter were achieved with DpnI-based
(New England Biolabs) site-directed mutagenesis with Phusion DNA Polymer-
ase. Sanger sequencing and restriction digestions confirmed sequence/frame
and orientation of fragments.
Nuclear RBP siRNA Screen
Cells were transfected with siRNAs at 5–20 nanomolar (nM) final concentration
using Lipofectamine RNAiMAX (Life Technologies) in 24-well plates, while
expression plasmids (1 mg) were transfected with Lipofectamine 2000 (Life
Technologies). For the circScreen reporter assay, siRNAs were transfected
into HEK293T cells 40 hr prior to transfection with the circScreen plasmid.
At five hours after circScreen transfection, the culture media was changed
to 1:3 DMEM:F-12 (Life Technologies) with 10% heat-inactivated fetal calf
serum and 13 Penicillin-Streptomycin to reduce green autofluorescence.
Cells were imaged on the IncuCyte Zoom (Essen Bioscience) capturing phase,
green, and red fluorescence images at 103 magnification over the next 48 hr
(refer to Figure S3 for detailed image analysis).
Incorporation of QREs into Minigene Reporters
There was four genes—SYT8, TIMP1, NACAD, and ADD3—that were chosen,
as they were devoid of any circRNAs. Genomic regions comprising three
exons and two introns were synthesized (Integrated DNA Technologies)
with and without consensus QREs (ACUAAC(N17)UAAC) approximately 100–
200 bp from the splicing site of the central exon. These were cloned into
pcDNA3.1 and transfected into HEK293T cells that had been transfected
40 hr previous with negative control siRNA or QKI ON-Targetplus SMART
pool siRNA (Dharmacon). RNA was isolated 24 hr later with TRIzol and treated
with Ribonuclease R (RNase R, Epicenter) as per Jeck et al. (2013), cDNA was
reverse transcribed using random hexamers and SuperScript III reverse tran-
scriptase (Life Technologies).
RNA Immunoprecipitation
MDA-MB-231 cells were UV cross-linked at 600mJ/cm2 and lysed in 13 PXL
lysis buffer (13 PBS, 0.1% SDS, 0.5% sodium deoxycholate, and 0.5%NP-40
with 13Protease Inhibitor Cocktail [Promega]). Lysate was treatedwith DNase
I (Roche) at 37C for 10 min and centrifuged at 12,000 g for 30 min. Total pro-
tein (1 mg) was indirectly immunoprecipitated with 5 mg of a-QKI-5 rabbit poly-
clonal antibody (Bethyl Laboratories, A300-183A), or rabbit anti-mouse IgG
antibody (Jackson Laboratories) as a control, and 100 ml of Protein Gmagnetic
dynabeads (Life Technologies). Beads were washed twice with 13 PXL lysis
buffer, followed by two washes each with 53 PXL and 13 PNK buffer
(50 mM Tris-Cl [pH7.5], 10 mM MgCl2, and 0.5% NP-40). There was thirty
percent of the immunoprecipitate that was set aside for western blot analysis,
with protein eluted from beads in 13 PNK buffer, 43 LDS Loading Buffer (Life
Technologies) and 4% b-mercaptoethanol at 70C for 10 min. There was
twenty percent of the immunoprecipitate that was treated for 20 min at 37C
with a Proteinase K solution (4 mg/ml Proteinase K in 100 mM Tris-Cl [pH
7.5], 50mMNaCl, and 10mMEDTA). An equal volume of Proteinase K solution
including 7 M urea was then added and incubated at 37C for a further 20 min,
after which the RNA was extracted using phenol:chloroform. Samples were
spun at 12,000 g, at 4C for 10 min. The aqueous phase was collected and
RNA precipitated overnight with 3 M sodium acetate [pH5.2], 20 mg glycogen,
and 1:1 ethanol:isopropanol. The RNA pellet was washed twice with 75%
ethanol, air-dried, and resuspended in water.
Establishment of Cell Lines Stably Overexpressing QKI cDNA
Human QKI-5 cDNA was PCR amplified from pENTR-QKI (Addgene plasmid
#16183) to include a stop codon and cloned into the BamHI and NotI sites
of the pENTR2B entry vector (Invitrogen). The resulting pENTR2B-QKI-5
vector was recombined with pLX301 (Addgene plasmid #25895) using LR Clo-
nase to generate pLX301-QKI-5. An expression vector containing mCherry
(pLX301-mCherry) was generated by recombination of pENTR2B-mCherry
with pLX301. Lentiviral particles were produced from pLX301-mCherry and
QKI-5 constructs by co-transfecting HEK293T cells with pCMV5-VSVG and
pCMV-dR8.2. A 1:8 dilution of virus was added to mesHMLE cells plated at
low density for 96 hr before selection with 1 mg/ml puromycin. Single clones
that overexpressed QKI-5 and a control mCherry clonal pool were used for
downstream experiments.
Establishment of Cell Lines Stably Overexpressing QKI shRNA
Lentiviral vectors for shRNA mediated knockdown of QKI were purchased
from Sigma-Aldrich (Mission pLKO; TRCN0000233372 and TRCN0000
233375) alongwith a non-targeting control shRNA (Mission SHC216). Lentiviral
particles and selection of stable mesHMLE pools were carried out as
described above for the pLX301 vectors.
Western Blotting
Western blotting was performed according to standard protocols and imaged
using the Odyssey CLx scanner (LI-COR). Primary antibodies used in this
study were as follows: anti a-tubulin mouse monoclonal (Abcam, ab7291,
1:10,000), anti-FLAG mouse monoclonal (Sigma, F1804, 1:4,000), anti-HA
mouse monoclonal (Sigma, H3663, 1:1,000), anti-QKI5 rabbit polyclonal
(Bethyl Laboratories, A300-183A, 1:5,000), and anti-E-cadherin mouse mono-
clonal (BD Biosciences, 610182, 1:1,000). Secondary antibodies used were,
Goat anti-mouse IRDye680 (LI-COR, 926-32220, 1:20,000), Goat anti-rabbit
IRDye680 (LI-COR, 926-32221, 1:20,000), Goat anti-mouse IRDye800 (LI-
COR, 926-32210, 1:20,000); Goat anti-rabbit IRDye800 (LI-COR, 926-32211,
1:20,000).ACCESSION NUMBERS
The European Nucleotide Archive accession number for the RNA sequencing
data reported in this paper is PRJEB8225.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and two tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2015.02.014.
AUTHOR CONTRIBUTIONS
S.J.C. designed the experiments with input from G.J.G. K.A.P., J.T., and
A.W.S. performed the bioinformatic analyses. P.A.G. performed HMLE EMT
time course and QKI knockdown experiments, purified RNA for qRT-PCR
and library preparation, and provided important advice and reagents. V.C. as-
sisted S.J.C. in synthesis of circScreen, performed circScreen quantification,
and RT-PCR validation of targets. M.S. performed QKI RNA immunoprecipita-
tion. C.A.P. generated QKI shRNA and overexpression lines with assistance
from P.A.G. and S.R. S.R. performed western blotting, proliferation assays,
and qRT-PCR across HMLE time course. All other experiments were per-
formed by S.J.C. The figures were prepared by S.J.C., G.J.G., and J.T., and
the manuscript was written by S.J.C. and G.J.G., with input from the other
authors.
ACKNOWLEDGMENTS
We thank all members of the Goodall Laboratory for valuable discussion. We
thank David Lawrence of the CCBACRFCancer Genomics Facility for valuable
discussion and for establishing sequencing analysis pipelines. Funding for this
research was obtained from the Royal Adelaide Hospital Research Fund in the
form of a Florey Postdoctoral Fellowship to S.J.C.; from the National Health
and Medical Research Council project grants GNT1089167 to G.J.G. and
S.J.C.; GNT1068773 to G.J.G. and P.A.G.; and from the EMPathy Breast Can-
cer Network, a National Breast Cancer Foundation (Australia)-funded National
Collaborative Research Program. P.A.G. is supported by a Cancer Council SA
Beat Cancer Fellowship.
Received: November 26, 2014
Revised: January 5, 2015
Accepted: February 3, 2015
Published: March 12, 2015
REFERENCES
Ashwal-Fluss, R., Meyer, M., Pamudurti, N.R., Ivanov, A., Bartok, O.,
Hanan, M., Evantal, N., Memczak, S., Rajewsky, N., and Kadener, S.
(2014). circRNA biogenesis competes with pre-mRNA splicing. Mol. Cell
56, 55–66.
Attema, J.L., Bert, A.G., Lim, Y.-Y., Kolesnikoff, N., Lawrence, D.M., Pillman,
K.A., Smith, E., Drew, P.A., Khew-Goodall, Y., Shannon, F., and Goodall,
G.J. (2013). Identification of an enhancer that increases miR-
200b200a429 gene expression in breast cancer cells. PLoS ONE 8,
e75517.
Brabletz, T. (2012). To differentiate or not—routes towards metastasis. Nat.
Rev. Cancer 12, 425–436.
Bracken, C.P., Li, X., Wright, J.A., Lawrence, D.M., Pillman, K.A., Salmanidis,
M., Anderson, M.A., Dredge, B.K., Gregory, P.A., Tsykin, A., et al. (2014).
Genome-wide identification of miR-200 targets reveals a regulatory network
controlling cell invasion. EMBO J. 33, 2040–2056.
Capel, B., Swain, A., Nicolis, S., Hacker, A., Walter, M., Koopman, P., Good-
fellow, P., and Lovell-Badge, R. (1993). Circular transcripts of the testis-deter-
mining gene Sry in adult mouse testis. Cell 73, 1019–1030.Cell 160, 1125–1134, March 12, 2015 ª2015 Elsevier Inc. 1133
Che´nard, C.A., and Stephane, R. (2008). New implications for the QUAKING
RNA binding protein in human disease. J. Neurosci. Res. 86, 233–242.
Cocquerelle, C., Mascrez, B., He´tuin, D., and Bailleul, B. (1993). Mis-splicing
yields circular RNA molecules. FASEB J. 7, 155–160.
Gadea, G., and Blangy, A. (2014). Dock-family exchange factors in cell migra-
tion and disease. Eur. J. Cell Biol. 93, 466–477.
Galarneau, A., and Richard, S. (2005). Target RNA motif and target mRNAs of
the Quaking STAR protein. Nat. Struct. Mol. Biol. 12, 691–698.
Gregory, P.A., Bert, A.G., Paterson, E.L., Barry, S.C., Tsykin, A., Farshid, G.,
Vadas, M.A., Khew-Goodall, Y., and Goodall, G.J. (2008). The miR-200 family
and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1
and SIP1. Nat. Cell Biol. 10, 593–601.
Gregory, P.A., Bracken, C.P., Smith, E., Bert, A.G., Wright, J.A., Roslan, S.,
Morris, M., Wyatt, L., Farshid, G., Lim, Y.Y., et al. (2011). An autocrine TGF-
beta/ZEB/miR-200 signaling network regulates establishment and mainte-
nance of epithelial-mesenchymal transition. Mol. Biol. Cell 22, 1686–1698.
Gualandi, F., Trabanelli, C., Rimessi, P., Calzolari, E., Toffolatti, L., Patarnello,
T., Kunz, G.,Muntoni, F., and Ferlini, A. (2003). Multiple exon skipping and RNA
circularisation contribute to the severe phenotypic expression of exon 5 dys-
trophin deletion. J. Med. Genet. 40, e100.
Guo, J.U., Agarwal, V., Guo, H., and Bartel, D.P. (2014). Expanded identifica-
tion and characterization of mammalian circular RNAs. Genome Biol. 15, 409.
Hafner, M., Landthaler, M., Burger, L., Khorshid, M., Hausser, J., Berninger, P.,
Rothballer, A., Ascano, M., Jr., Jungkamp, A.-C., Munschauer, M., et al.
(2010). Transcriptome-wide identification of RNA-binding protein and micro-
RNA target sites by PAR-CLIP. Cell 141, 129–141.
Hall, M.P., Nagel, R.J., Fagg, W.S., Shiue, L., Cline, M.S., Perriman, R.J., Do-
nohue, J.P., and Ares, M., Jr. (2013). Quaking and PTB control overlapping
splicing regulatory networks during muscle cell differentiation. RNA 19,
627–638.
Hansen, T.B., Jensen, T.I., Clausen, B.H., Bramsen, J.B., Finsen, B., Dam-
gaard, C.K., and Kjems, J. (2013). Natural RNA circles function as efficient mi-
croRNA sponges. Nature 495, 384–388.
Jeck, W.R., and Sharpless, N.E. (2014). Detecting and characterizing circular
RNAs. Nat. Biotechnol. 32, 453–461.
Jeck, W.R., Sorrentino, J.A., Wang, K., Slevin, M.K., Burd, C.E., Liu, J., Mar-
zluff, W.F., and Sharpless, N.E. (2013). Circular RNAs are abundant,
conserved, and associated with ALU repeats. RNA 19, 141–157.
Kalsotra, A., and Cooper, T.A. (2011). Functional consequences of develop-
mentally regulated alternative splicing. Nat. Rev. Genet. 12, 715–729.
Lamouille, S., Xu, J., and Derynck, R. (2014). Molecular mechanisms of epithe-
lial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178–196.
Larocque, D., Galarneau, A., Liu, H.-N., Scott, M., Almazan, G., andRichard, S.
(2005). Protection of p27(Kip1) mRNA by quaking RNA binding proteins pro-
motes oligodendrocyte differentiation. Nat. Neurosci. 8, 27–33.
Lasda, E., and Parker, R. (2014). Circular RNAs: diversity of form and function.
RNA 20, 1829–1842.
Liang, D., andWilusz, J.E. (2014). Short intronic repeat sequences facilitate cir-
cular RNA production. Genes Dev. 28, 2233–2247.
Mani, S.A., Guo, W., Liao, M.-J., Eaton, E.N., Ayyanan, A., Zhou, A.Y., Brooks,
M., Reinhard, F., Zhang, C.C., Shipitsin, M., et al. (2008). The epithelial-mesen-
chymal transition generates cells with properties of stem cells. Cell 133,
704–715.
Martin, M. (2011). Cutadapt removes adapter sequences from high-
throughput sequencing reads. EMBnet.journal 17, 10–12.1134 Cell 160, 1125–1134, March 12, 2015 ª2015 Elsevier Inc.Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier,
L., Mackowiak, S.D., Gregersen, L.H., Munschauer, M., et al. (2013). Circular
RNAs are a large class of animal RNAs with regulatory potency. Nature 495,
333–338.
Nieto, M.A. (2013). Epithelial plasticity: a common theme in embryonic and
cancer cells. Science 342, 1234850.
Nigro, J.M., Cho, K.R., Fearon, E.R., Kern, S.E., Ruppert, J.M., Oliner, J.D.,
Kinzler, K.W., and Vogelstein, B. (1991). Scrambled exons. Cell 64, 607–613.
Pilotte, J., Larocque, D., and Richard, S. (2001). Nuclear translocation
controlled by alternatively spliced isoforms inactivates the QUAKING
apoptotic inducer. Genes Dev. 15, 845–858.
Saccomanno, L., Loushin, C., Jan, E., Punkay, E., Artzt, K., and Goodwin, E.B.
(1999). The STAR protein QKI-6 is a translational repressor. Proc. Natl. Acad.
Sci. USA 96, 12605–12610.
Salzman, J., Gawad, C., Wang, P.L., Lacayo, N., and Brown, P.O. (2012). Cir-
cular RNAs are the predominant transcript isoform from hundreds of human
genes in diverse cell types. PLoS ONE 7, e30733.
Salzman, J., Chen, R.E., Olsen, M.N., Wang, P.L., and Brown, P.O. (2013).
Cell-type specific features of circular RNA expression. PLoS Genet. 9,
e1003777.
Scheel, C., and Weinberg, R.A. (2012). Cancer stem cells and epithelial-
mesenchymal transition: concepts and molecular links. Semin. Cancer Biol.
22, 396–403.
Suzuki, H., Zuo, Y., Wang, J., Zhang, M.Q., Malhotra, A., and Mayeda, A.
(2006). Characterization of RNase R-digested cellular RNA source that con-
sists of lariat and circular RNAs from pre-mRNA splicing. Nucleic Acids Res.
34, e63.
Teplova, M., Hafner, M., Teplov, D., Essig, K., Tuschl, T., and Patel, D.J. (2013).
Structure-function studies of STAR family Quaking proteins bound to their
in vivo RNA target sites. Genes Dev. 27, 928–940.
Tsai, J.H., and Yang, J. (2013). Epithelial-mesenchymal plasticity in carcinoma
metastasis. Genes Dev. 27, 2192–2206.
Wang, K., Singh, D., Zeng, Z., Coleman, S.J., Huang, Y., Savich, G.L., He, X.,
Mieczkowski, P., Grimm, S.A., Perou, C.M., et al. (2010). MapSplice: accurate
mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res.
38, e178.
Wang, P.L., Bao, Y., Yee, M.-C., Barrett, S.P., Hogan, G.J., Olsen, M.N., Din-
neny, J.R., Brown, P.O., and Salzman, J. (2014a). Circular RNA is expressed
across the eukaryotic tree of life. PLoS ONE 9, e90859.
Wang, X., Haswell, J.R., and Roberts, C.W.M. (2014b). Molecular pathways:
SWI/SNF (BAF) complexes are frequently mutated in cancer—mechanisms
and potential therapeutic insights. Clin. Cancer Res. 20, 21–27.
Wilusz, J.E., and Sharp, P.A. (2013). Molecular biology. A circuitous route to
noncoding RNA. Science 340, 440–441.
Wu, J.I., Reed, R.B., Grabowski, P.J., and Artzt, K. (2002). Function of quaking
in myelination: regulation of alternative splicing. Proc. Natl. Acad. Sci. USA 99,
4233–4238.
Zaphiropoulos, P.G. (1997). Exon skipping and circular RNA formation in tran-
scripts of the human cytochrome P-450 2C18 gene in epidermis and of the rat
androgen binding protein gene in testis. Mol. Cell. Biol. 17, 2985–2993.
Zhang, X.-O., Wang, H.-B., Zhang, Y., Lu, X., Chen, L.-L., and Yang, L. (2014).
Complementary sequence-mediated exon circularization. Cell 159, 134–147.
Zong, F.-Y., Fu, X., Wei, W.-J., Luo, Y.-G., Heiner, M., Cao, L.-J., Fang, Z.,
Fang, R., Lu, D., Ji, H., and Hui, J. (2014). The RNA-binding protein QKI sup-
presses cancer-associated aberrant splicing. PLoS Genet. 10, e1004289.
